TBI and sex: Crucial role of progesterone protecting the brain in an omega-3 deficient condition

Experimental Neurology

Volumn 253, Issue , 2014, Pages 41-51

  Tyagi, Ethika ^a   Agrawal, Rahul ^a   Ying, Zhe ^a   Gomez Pinilla, Fernando ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Neuroplasticity; Omega 3 fatty acid; Progesterone; Traumatic brain injury

Indexed keywords

4 HYDROXYNONENAL; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; FOLIC ACID; MYELIN ASSOCIATED GLYCOPROTEIN; NEUROMODULIN; NEUROPEPTIDE Y1 RECEPTOR; OMEGA 3 FATTY ACID; PROGESTERONE; PROTEIN NOGO A; SECRETORY PHOSPHOLIPASE A2; SYNTAXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN DEVELOPMENT; COMPARATIVE STUDY; DIET RESTRICTION; DRUG EFFICACY; FAT INTAKE; FEMALE; FOOD DRUG INTERACTION; HIPPOCAMPUS; HOMEOSTASIS; MEMBRANE STABILIZATION; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SYNAPTIC EFFICACY; SYNAPTIC MEMBRANE; TRAUMATIC BRAIN INJURY;

ANXIETY; NEUROPLASTICITY; OMEGA-3 FATTY ACID; PROGESTERONE; TRAUMATIC BRAIN INJURY;

ANIMALS; ANIMALS, NEWBORN; ANXIETY; BRAIN INJURIES; DIETARY FATS; DISEASE MODELS, ANIMAL; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FEMALE; GAP-43 PROTEIN; MALE; MAZE LEARNING; MYELIN PROTEINS; MYELIN-ASSOCIATED GLYCOPROTEIN; NEUROPEPTIDE Y; OVARIECTOMY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROGESTERONE; PROGESTINS; QA-SNARE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS;

EID: 84891947655     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.12.004     Document Type: Article

References (81)

1. Andrade S., Arbo B.D., Batista B.A., Neves A.M., Branchini G., Brum I.S., Barros H.M., Gomez R., Ribeiro M.F. Effect of progesterone on the expression of GABA(A) receptor subunits in the prefrontal cortex of rats: implications of sex differences and brain hemisphere. Cell Biochem. Funct. 2012, 30:696-700.
2. Ariza M., Serra-Grabulosa J.M., Junqué C., Ramírez B., Mataró M., Poca A., Bargalló N., Sahuquillo J. Hippocampal head atrophy after traumatic brain injury. Neuropsychologia 2006, 44:1956-1961.
3. Bailes J.E., Mills J.D. Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model. J. Neurotrauma 2010, 27:1617-1624.
4. Bali N., Arimoto J.M., Iwata N., Lin S.W., Zhao L., Brinton R.D., Morgan T.E., Finch C.E. Differential responses of progesterone receptor membrane component-1 (Pgrmc1) and the classical progesterone receptor (Pgr) to 17β-estradiol and progesterone in hippocampal subregions that support synaptic remodeling and neurogenesis. Endocrinology 2012, 153:759-769.
5. Barha C.K., Ishrat T., Epp J.R., Galea L.A., Stein D.G. Progesterone treatment normalizes the levels of cell proliferation and cell death in the dentate gyrus of the hippocampus after traumatic brain injury. Exp. Neurol. 2011, 231:72-81.
6. Basselin M., Rosa A.O., Ramadan E., Cheon Y., Chang L., Chen M., Greenstein D., Wohltmann M., Turk J., Rapoport S.I. Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA(2)β (VIA)-deficient mice. J. Lipid Res. 2010, 51:3166-3173.
7. Benowitz L.I., Rodriguez W.R., Neve R.L. The pattern of GAP-43 immunostaining changes in the rat hippocampal formation during reactive synaptogenesis. Brain Res. Mol. Brain Res. 1990, 8:17-23.
8. Betz A.L., Coester H.C. Effect of steroids on edema and sodium uptake of the brain during focal ischemia in rats. Stroke 1990, 21:1199-1204.
9. Bleakman D., Harrison N.L., Colmers W.F., Miller R.J. Investigations into neuropeptide Y-mediated presynaptic inhibition in cultured hippocampal neurones of the rat. Br. J. Pharmacol. 1992, 107:334-340.
10. Cai D., Shen Y., De Bellard M., Tang S., Filbin M.T. Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron 1999, 22:89-101.
11. Camacho-Arroyo I., Montor J.M. Beyond reproductive effects of sex steroids. Mini Rev. Med. Chem. 2012, 12:1037-1039.
12. Carobrez A.P., Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20years on. Neurosci. Biobehav. Rev. 2005, 29:1193-1205.
13. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000, 403:434-439.
14. Cowansage K.K., LeDoux J.E., Monfils M.H. Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. Curr. Mol. Pharmacol. 2010, 3:12-29.
15. Croll S.D., Ip N.Y., Lindsay R.M., Wiegand S.J. Expression of BDNF and trkB as a function of age and cognitive performance. Brain Res. 1998, 812:200-208.
16. Cutler S.M., VanLandingham J.W., Murphy A.Z., Stein D.G. Slow-release and injected progesterone treatments enhance acute recovery after traumatic brain injury. Pharmacol. Biochem. Behav. 2006, 84:420-428.
17. Cutler S.M., Vanlandingham J.W., Stein D.G. Tapered progesterone withdrawal promotes long-term recovery following brain trauma. Exp. Neurol. 2006, 200:378-385.
18. Darios F., Davletov B. Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature 2006, 440:813-817.
19. De Nicola A.F., Gonzalez S.L., Labombarda F., Deniselle M.C., Garay L., Guennoun R., Schumacher M. Progesterone treatment of spinal cord injury: effects on receptors, neurotrophins, and myelination. J. Mol. Neurosci. 2006, 28:3-15.
20. Deecher D., Andree T.H., Sloan D., Schechter L.E. From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology 2008, 33:3-17.
21. Djebaili M., Guo Q., Pettus E.H., Hoffman S.W., Stein D.G. The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J. Neurotrauma 2005, 22:106-118.
22. Emery D.L., Royo N.C., Fischer I., Saatman K.E., McIntosh T.K. Plasticity following injury to the adult central nervous system: is recapitulation of a developmental state worth promoting?. J. Neurotrauma 2003, 20:1271-1292.
23. Fedorova I., Hussein N., Baumann M.H., Di Martino C., Salem N. An n-3 fatty acid deficiency impairs rat spatial learning in the Barnes maze. Behav. Neurosci. 2009, 123:196-205.
24. Feng Z., Hu W., Tang M.S. Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: a possible mechanism for lipid peroxidation-induced carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:8598-8602.
25. Filbin M.T. Myelin-associated glycoprotein: a role in myelination and in the inhibition of axonal regeneration?. Curr. Opin. Neurobiol. 1995, 5:588-595.
26. Gibson C.L., Coomber B., Murphy S.P. Progesterone is neuroprotective following cerebral ischaemia in reproductively ageing female mice. Brain 2011, 134:2125-2133.
27. Giesbrecht C.J., Mackay J.P., Silveira H.B., Urban J.H., Colmers W.F. Countervailing modulation of Ih by neuropeptide Y and corticotrophin-releasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviors. J. Neurosci. 2010, 30:16970-16982.
28. Giza C.C., Prins M.L., Hovda D.A., Herschman H.R., Feldman J.D. Genes preferentially induced by depolarization after concussive brain injury: effects of age and injury severity. J. Neurotrauma 2002, 19:387-402.
29. Gomez-Pinilla F. Brain foods: the effects of nutrients on brain function. Nat. Rev. Neurosci. 2008, 9:568-578.
30. Goss C.W., Hoffman S.W., Stein D.G. Behavioral effects and anatomic correlates after brain injury: a progesterone dose-response study. Pharmacol. Biochem. Behav. 2003, 76:231-242.
31. Gurkoff G.G., Giza C.C., Hovda D.A. Lateral fluid percussion injury in the developing rat causes an acute, mild behavioral dysfunction in the absence of significant cell death. Brain Res. 2006, 1077:24-36.
32. Hall J., Thomas K.L., Everitt B.J. Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat. Neurosci. 2000, 3:533-535.
33. Harauma A., Moriguchi T. Dietary n-3 fatty acid deficiency in mice enhances anxiety induced by chronic mild stress. Lipids 2011, 46:409-416.
34. Hsu C.Y., Liu T.H., Xu J., Hogan E.L., Chao J., Sun G., Tai H.H., Beckman J.S., Freeman B.A. Arachidonic acid and its metabolites in cerebral ischemia. Ann. N. Y. Acad. Sci. 1989, 559:282-295.
35. Jacka F.N., Pasco J.A., Williams L.J., Meyer B.J., Digger R., Berk M. Dietary intake of fish and PUFA, and clinical depressive and anxiety disorders in women. Br. J. Nutr. 2013, 109:2059-2066.
36. Kalyvas A., David S. Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron 2004, 41:323-335.
37. Kang J.X., Gleason E.D. Omega-3 fatty acids and hippocampal neurogenesis in depression. CNS Neurol. Disord. Drug Targets 2013, 12:460-465.
38. Kheirbek M.A., Drew L.J., Burghardt N.S., Costantini D.O., Tannenholz L., Ahmari S.E., Zeng H., Fenton A.A., Hen R. Differential control of learning and anxiety along the dorsoventral axis of the dentate gyrus. Neuron 2013, 77:955-968.
39. Kinsley C.H., Meyer E., Rafferty K.A. Sex steroid hormone determination of the maternal brain: effects beyond reproduction. Mini Rev. Med. Chem. 2012, 12:1063-1070.
40. Kishimoto K., Matsumura K., Kataoka Y., Morii H., Watanabe Y. Localization of cytosolic phospholipase A2 messenger RNA mainly in neurons in the rat brain. Neuroscience 1999, 92:1061-1077.
41. Lewis M.D., Hibbeln J.R., Johnson J.E., Lin Y.H., Hyun D.Y., Loewke J.D. Suicide deaths of active-duty US military and ω-3 fatty-acid status: a case-control comparison. J. Clin. Psychiatry 2011, 72:1585-1590.
42. Marcondes F.K., Miguel K.J., Melo L.L., Spadari-Bratfisch R.C. Estrous cycle influences the response of female rats in the elevated plus-maze test. Physiol. Behav. 2001, 74:435-440.
43. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J. Neurochem. 1997, 68:255-264.
44. Martín-Martín B., Nabokina S.M., Lazo P.A., Mollinedo F. Co-expression of several human syntaxin genes in neutrophils and differentiating HL-60 cells: variant isoforms and detection of syntaxin 1. J. Leukoc. Biol. 1999, 65:397-406.
45. McNamara R.K., Hahn C.G., Jandacek R., Rider T., Tso P., Stanford K.E., Richtand N.M. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol. Psychiatry 2007, 62:17-24.
46. Melcangi R.C., Cavarretta I.T., Ballabio M., Leonelli E., Schenone A., Azcoitia I., Miguel Garcia-Segura L., Magnaghi V. Peripheral nerves: a target for the action of neuroactive steroids. Brain Res. Brain Res. Rev. 2005, 48:328-338.
47. Miller D.M., Singh I.N., Wang J.A., Hall E.D. Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo. Free Radic. Biol. Med. 2013, 57:1-9.
48. Mills J.D., Hadley K., Bailes J.E. Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury. Neurosurgery 2011, 68:474-481. (discussion 481).
49. Molloy G.Y., Rattray M., Williams R.J. Genes encoding multiple forms of phospholipase A2 are expressed in rat brain. Neurosci. Lett. 1998, 258:139-142.
50. Morrow A.L., Devaud L.L., Purdy R.H., Paul S.M. Neuroactive steroid modulators of the stress response. Ann. N. Y. Acad. Sci. 1995, 771:257-272.
51. O'Connor C.A., Cernak I., Johnson F., Vink R. Effects of progesterone on neurologic and morphologic outcome following diffuse traumatic brain injury in rats. Exp. Neurol. 2007, 205:145-153.
52. Phillis J.W., O'Regan M.H. A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders. Brain Res. Brain Res. Rev. 2004, 44:13-47.
53. Prevot V., Bouret S., Croix D., Alonso G., Jennes L., Mitchell V., Routtenberg A., Beauvillain J.C. Growth-associated protein-43 messenger ribonucleic acid expression in gonadotropin-releasing hormone neurons during the rat estrous cycle. Endocrinology 2000, 141:1648-1657.
54. Primeaux S.D., Wilson S.P., Cusick M.C., York D.A., Wilson M.A. Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors. Neuropsychopharmacology 2005, 30:1589-1597.
55. Rehncrona S., Westerberg E., Akesson B., Siesjö B.K. Brain cortical fatty acids and phospholipids during and following complete and severe incomplete ischemia. J. Neurochem. 1982, 38:84-93.
56. Robinson J.G., Ijioma N., Harris W. Omega-3 fatty acids and cognitive function in women. Womens Health (Lond. Engl.) 2010, 6:119-134.
57. Roof R.L., Hall E.D. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J. Neurotrauma 2000, 17:367-388.
58. Roof R.L., Duvdevani R., Stein D.G. Progesterone treatment attenuates brain edema following contusion injury in male and female rats. Restor. Neurol. Neurosci. 1992, 4:425-427.
59. Roof R.L., Duvdevani R., Stein D.G. Gender influences outcome of brain injury: progesterone plays a protective role. Brain Res. 1993, 607:333-336.
60. Roof R.L., Duvdevani R., Braswell L., Stein D.G. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp. Neurol. 1994, 129:64-69.
61. Roof R.L., Duvdevani R., Heyburn J.W., Stein D.G. Progesterone rapidly decreases brain edema: treatment delayed up to 24hours is still effective. Exp. Neurol. 1996, 138:246-251.
62. Roof R.L., Hoffman S.W., Stein D.G. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol. Chem. Neuropathol. 1997, 31:1-11.
63. Schwab M.E. Nogo and axon regeneration. Curr. Opin. Neurobiol. 2004, 14:118-124.
64. Schwab M.E. Functions of Nogo proteins and their receptors in the nervous system. Nat. Rev. Neurosci. 2010, 11:799-811.
65. Shear D.A., Galani R., Hoffman S.W., Stein D.G. Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury. Exp. Neurol. 2002, 178:59-67.
66. Shibata A., Wright M.V., David S., McKerracher L., Braun P.E., Kater S.B. Unique responses of differentiating neuronal growth cones to inhibitory cues presented by oligodendrocytes. J. Cell Biol. 1998, 142:191-202.
67. Simopoulos A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother. 2006, 60:502-507.
68. Stein D.G. Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?. Trends Neurosci. 2001, 24:386-391.
69. Stein D.G., Wright D.W. Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin. Investig. Drugs 2010, 19:847-857.
70. Sun G.Y., Xu J., Jensen M.D., Simonyi A. Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J. Lipid Res. 2004, 45:205-213.
71. Takeuchi T., Iwanaga M., Harada E. Possible regulatory mechanism of DHA-induced anti-stress reaction in rats. Brain Res. 2003, 964:136-143.
72. Timonen M., Horrobin D., Jokelainen J., Laitinen J., Herva A., Räsänen P. Fish consumption and depression: the Northern Finland 1966 birth cohort study. J. Affect. Disord. 2004, 82:447-452.
73. Tyagi E., Agrawal R., Zhuang Y., Abad C., Waschek J.A., Gomez-Pinilla F. Vulnerability imposed by diet and brain trauma for anxiety-like phenotype: implications for post-traumatic stress disorders. PLoS One 2013, 8:e57945.
74. Walf A.A., Frye C.A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2007, 2:322-328.
75. Wang T., Van K.C., Gavitt B.J., Grayson J.K., Lu Y.C., Lyeth B.G., Pichakron K.O. Effect of fish oil supplementation in a rat model of multiple mild traumatic brain injuries. Restor. Neurol. Neurosci. 2013, 31:647-659.
76. Wohltmann C.D., Franklin G.A., Boaz P.W., Luchette F.A., Kearney P.A., Richardson J.D., Spain D.A. A multicenter evaluation of whether gender dimorphism affects survival after trauma. Am. J. Surg. 2001, 181:297-300.
77. Wu A., Ying Z., Gómez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J. Neurotrauma 2004, 21:1457-1467.
78. Wu A., Ying Z., Gomez-Pinilla F. Omega-3 fatty acids supplementation restores mechanisms that maintain brain homeostasis in traumatic brain injury. J. Neurotrauma 2007, 24:1587-1595.
79. Wu A., Ying Z., Gomez-Pinilla F. The salutary effects of DHA dietary supplementation on cognition, neuroplasticity, and membrane homeostasis after brain trauma. J. Neurotrauma 2011, 28:2113-2122.
80. Yiu G., He Z. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. 2006, 7:617-627.
81. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). ISBN 978-0-309-08525-0. A Report of the Panel on Macronutrients, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Institute of Medicine., 2002/2005. URL: (Last Accessed on Nov'5' 2013). http://www.nap.edu/catalog.php?record_id=10490.